Merck KGaA
MKGAF
$136.74
-$5.67-3.98%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.43% | 2.26% | 1.31% | 0.79% | -0.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.43% | 2.26% | 1.31% | 0.79% | -0.56% |
| Cost of Revenue | 3.22% | 1.63% | -1.51% | 0.85% | 2.88% |
| Gross Profit | 3.58% | 2.71% | 3.34% | 0.76% | -2.83% |
| SG&A Expenses | 6.47% | 4.10% | 2.47% | 1.88% | -1.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -97.29% | -52.17% | 23.71% | -18.21% | 189.48% |
| Total Operating Expenses | -0.43% | -1.40% | -0.63% | -0.46% | 3.82% |
| Operating Income | 22.43% | 20.91% | 10.61% | 6.65% | -17.64% |
| Income Before Tax | 12.73% | 12.04% | 5.46% | 1.57% | -7.16% |
| Income Tax Expenses | 16.25% | 21.65% | 19.20% | 15.54% | -13.17% |
| Earnings from Continuing Operations | 11.87% | 9.73% | 2.25% | -1.63% | -5.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 41.75% | -71.70% | 42.41% | 17.79% | 41.20% |
| Net Income | 12.03% | 9.57% | 2.45% | -1.57% | -5.38% |
| EBIT | 22.43% | 20.91% | 10.61% | 6.65% | -17.64% |
| EBITDA | 16.17% | 14.67% | 7.70% | 5.02% | -9.94% |
| EPS Basic | 11.82% | 9.41% | 2.41% | -1.47% | -5.28% |
| Normalized Basic EPS | 17.16% | 16.30% | 10.52% | 6.69% | -11.66% |
| EPS Diluted | 11.91% | 9.50% | 2.49% | -1.39% | -5.36% |
| Normalized Diluted EPS | 17.16% | 16.30% | 10.52% | 6.69% | -11.66% |
| Average Basic Shares Outstanding | 0.18% | 0.14% | 0.02% | -0.11% | -0.11% |
| Average Diluted Shares Outstanding | 0.18% | 0.14% | 0.02% | -0.11% | -0.11% |
| Dividend Per Share | -0.99% | -0.99% | -0.99% | -0.99% | 5.37% |
| Payout Ratio | -0.05% | -0.03% | -0.11% | -0.10% | -0.06% |